Business Description
U2Bio Co Ltd
ISIN : KR7221800006
Compare
Compare
Traded in other countries / regions
221800.Korea IPO Date
2015-06-29Description
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 135.92 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 2.48 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 4.75 | |||||
| Beneish M-Score | -1.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.6 | |||||
| 3-Year EBITDA Growth Rate | -6.9 | |||||
| 3-Year Book Growth Rate | 62.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.67 | |||||
| 9-Day RSI | 29.47 | |||||
| 14-Day RSI | 33.6 | |||||
| 6-1 Month Momentum % | -19.52 | |||||
| 12-1 Month Momentum % | -57.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.78 | |||||
| Quick Ratio | 6.66 | |||||
| Cash Ratio | 5.4 | |||||
| Days Inventory | 29.79 | |||||
| Days Sales Outstanding | 231.54 | |||||
| Days Payable | 111.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.04 | |||||
| Forward Dividend Yield % | 1.04 | |||||
| 5-Year Yield-on-Cost % | 1.04 | |||||
| 3-Year Average Share Buyback Ratio | -14.1 | |||||
| Shareholder Yield % | 0.67 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 22.91 | |||||
| Operating Margin % | -8.66 | |||||
| Net Margin % | -2.98 | |||||
| FCF Margin % | -14.92 | |||||
| ROE % | -1.02 | |||||
| ROA % | -0.8 | |||||
| ROIC % | -15.39 | |||||
| ROC (Joel Greenblatt) % | -10.47 | |||||
| ROCE % | -0.89 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.24 | |||||
| PB Ratio | 0.87 | |||||
| Price-to-Tangible-Book | 0.89 | |||||
| EV-to-EBIT | 5.27 | |||||
| EV-to-EBITDA | -18.04 | |||||
| EV-to-Revenue | -0.15 | |||||
| EV-to-FCF | 0.6 | |||||
| Price-to-Projected-FCF | 0.42 | |||||
| Price-to-Net-Current-Asset-Value | 0.97 | |||||
| Price-to-Net-Cash | 1.32 | |||||
| Earnings Yield (Greenblatt) % | 18.98 | |||||
| FCF Yield % | -5.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
U2Bio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 12,342.836 | ||
| EPS (TTM) (â‚©) | -33 | ||
| Beta | 0.06 | ||
| Volatility % | 32.17 | ||
| 14-Day RSI | 33.6 | ||
| 14-Day ATR (â‚©) | 183.228002 | ||
| 20-Day SMA (â‚©) | 2995.75 | ||
| 12-1 Month Momentum % | -57.12 | ||
| 52-Week Range (â‚©) | 2775 - 10950 | ||
| Shares Outstanding (Mil) | 11.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
U2Bio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
U2Bio Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
U2Bio Co Ltd Frequently Asked Questions
What is U2Bio Co Ltd(XKRX:221800)'s stock price today?
The current price of XKRX:221800 is â‚©2865.00. The 52 week high of XKRX:221800 is â‚©10950.00 and 52 week low is â‚©2775.00.
When is next earnings date of U2Bio Co Ltd(XKRX:221800)?
The next earnings date of U2Bio Co Ltd(XKRX:221800) is .
Does U2Bio Co Ltd(XKRX:221800) pay dividends? If so, how much?
The Dividend Yield %  of U2Bio Co Ltd(XKRX:221800) is 1.04% (As of Today), Highest Dividend Payout Ratio of U2Bio Co Ltd(XKRX:221800) was 0.44. The lowest was 0.08. And the median was 0.38. The  Forward Dividend Yield % of U2Bio Co Ltd(XKRX:221800) is 1.04%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers